Cell and Gene Therapy Foundations Course

Name: Cell and Gene Therapy Foundations and Delivery Course
Availability: InStock

Build a cross-functional view of cell and gene therapy products, lifecycle interfaces, identity controls, delivery, and safety follow-up.

Cell and Gene Therapy Foundations Course

At a glance

Duration: 1 Week
Format: Classroom
Cities: Vienna, Chicago, Casablanca, Lisbon, Barcelona, London and more
Next session: 2 – 6 November 2026, Vienna
Average fee: 5,750 €

Home
Our Categories
Cell and Gene Therapy Foundations and Delivery Course

Download Brochure (PDF) Print PDF

Overview

Cell and Gene Therapy Foundations and Delivery Course is a one-week foundation course for healthcare, biotechnology, pharmaceutical, quality, clinical operations, and patient-access personnel, who leave with a Cell and Gene Therapy Pathway Map. The course explains product types, scientific concepts, development and manufacturing interfaces, identity controls, clinical handoffs, safety monitoring, and cross-functional governance without laboratory or prescribing instruction. Agile Leaders Training Center presents cell and gene therapy foundations for coordinated product delivery.

Who Should Attend

Teams responsible for cell and gene therapy service readiness
Personnel supporting biotechnology and pharmaceutical operations
Functions responsible for quality, logistics, and product handoffs
Teams supporting clinical operations and patient pathways
Personnel responsible for access, governance, and safety interfaces

The course assumes no laboratory specialization and leaves out product manufacture, clinical prescribing, patient-specific decisions, and jurisdiction-specific regulatory advice.

Departments and Industries

The course supports organizations that coordinate advanced therapy products across development, supply, care delivery, and follow-up.

Biotechnology and biopharmaceutical organizations
Hospital cell therapy and specialist care services
Clinical research and trial operations units
Quality, supply chain, laboratory, and pharmacy interfaces
Patient access, health technology, and service-planning teams

Learning Objectives

By the end of this course, participants will be able to:

Compare major cell, tissue, and gene therapy product types
Use in vivo, ex vivo, autologous, and allogeneic distinctions
Analyze development, manufacturing, and release interfaces
Build chain-of-identity and chain-of-custody process maps
Evaluate clinical handoffs and long-term safety monitoring needs
Prioritize cross-functional readiness and governance actions

Course Agenda

Day 1: Products and Scientific Foundations

Cell, Tissue, and Gene Therapy Product Classification Map
In Vivo and Ex Vivo Delivery Comparison
Autologous and Allogeneic Product Decision Grid
Viral and Nonviral Vector Concept Map
Gene Addition, Editing, and Cell Engineering Overview

Day 2: Development and Manufacturing Lifecycle

Discovery-to-Delivery Lifecycle Map
Starting Material and Donor Source Trace
Process Development and Critical Quality Attribute Matrix
Manufacturing Change and Comparability Concept Guide
Product Testing and Release Interface Map

Day 3: Identity, Custody, and Logistics

Patient and Product Chain-of-Identity Map
Chain-of-Custody Handoff Record
Collection and Apheresis Process Interface
Cryopreservation, Storage, and Transport Control Map
Exception, Deviation, and Escalation Decision Tree

Day 4: Clinical Delivery and Follow-Up

Center Readiness and Multidisciplinary Role Matrix
Patient Journey and Scheduling Dependency Map
Product Receipt, Preparation, and Administration Handoff
Immediate Safety Observation and Reporting Interface
Long-Term Follow-Up and Pharmacovigilance Map

Day 5: Cell and Gene Therapy Pathway Practice

Suggested Exercise: Product Classification Decisions
Suggested Exercise: Lifecycle and Quality Interface Mapping
Suggested Exercise: Identity and Custody Control Review
Suggested Exercise: Clinical Delivery and Follow-Up Planning
Capstone Exercise: Cell and Gene Therapy Pathway Map

Practical Exercises

The course uses suggested activities with fictional product-development, manufacturing, logistics, hospital, and follow-up scenarios.

Suggested activity: classify product examples and map in vivo, ex vivo, autologous, and allogeneic features.
Suggested activity: trace lifecycle interfaces, quality information, and release dependencies.
Suggested activity: identify patient-product handoffs and failure points in identity and custody.
Suggested activity: build a service pathway linking readiness, delivery, monitoring, and governance.

FAQs

Who suits cell and gene therapy foundations training, and what does it assume?

Healthcare, biotechnology, pharmaceutical, quality, clinical operations, logistics, access, and service-planning personnel suit the course; it assumes no laboratory specialization.

How does cell and gene therapy foundations training differ from laboratory training?

Cell and gene therapy foundations training explains product categories, lifecycle interfaces, identity controls, delivery pathways, and safety follow-up rather than teaching laboratory methods, manufacturing execution, or clinical procedures.

What is the difference between in vivo and ex vivo gene therapy?

In vivo gene therapy delivers genetic material within the body, while ex vivo approaches modify cells outside the body before they are returned through a controlled clinical pathway.

Why do cell and gene therapies require chain-of-identity controls?

Chain-of-identity controls maintain the documented link between a patient, collected material, manufactured product, transport stages, receipt, and administration so that each handoff preserves the intended match.

Conclusion

Participants leave with a Cell and Gene Therapy Pathway Map containing classification, lifecycle, quality-interface, identity, custody, logistics, delivery, monitoring, and governance tools. The map turns specialist terminology into connected cross-functional responsibilities. It helps teams locate handoffs, dependencies, evidence needs, and escalation points across the product-to-patient pathway.

credits: 5 credit per day

Course Mode: full-time

Provider: Agile Leaders Training Center

Download Brochure (PDF) Print PDF

Showing 61-75 of 75 events

Location	Dates	Duration	Mode	Price
Accra	Week 32, 2027 15 – 19 August 2027	1 Week	Onsite	€4,100
Dubai	Week 33, 2027 16 – 20 August 2027	1 Week	Onsite	€4,500
Rome	Week 34, 2027 23 – 27 August 2027	1 Week	Onsite	€5,700
Langkawi	Week 34, 2027 29 August – 2 September 2027	1 Week	Onsite	€6,000
Marbella	Week 34, 2027 29 August – 2 September 2027	1 Week	Onsite	€5,700
London	Week 36, 2027 6 – 10 September 2027	1 Week	Onsite	€5,700
Geneva	Week 36, 2027 12 – 16 September 2027	1 Week	Onsite	€6,200
Barcelona	Week 38, 2027 20 – 24 September 2027	1 Week	Onsite	€5,700
Montreux	Week 39, 2027 27 September – 1 October 2027	1 Week	Onsite	€7,500
Abu Dhabi	Week 39, 2027 27 September – 1 October 2027	1 Week	Onsite	€4,700
Seoul	Week 40, 2027 4 – 8 October 2027	1 Week	Onsite	€10,000
Bangkok	Week 40, 2027 10 – 14 October 2027	1 Week	Onsite	€6,000
Madrid	Week 42, 2027 18 – 22 October 2027	1 Week	Onsite	€5,700
San Diego	Week 43, 2027 25 – 29 October 2027	1 Week	Onsite	€14,000
Amman	Week 43, 2027 31 October – 4 November 2027	1 Week	Onsite	€4,100

Frequently asked questions

What does this course cover?

OverviewCell and Gene Therapy Foundations and Delivery Course is a one-week foundation course for healthcare, biotechnology, pharmaceutical, quality, clinical operations, and patient-access personnel, who leave with a Cell and Gene Therapy Pathway Map. The course explains product types, scientific concepts, development and manufacturing interfaces, identi…

Are training dates available?

Yes. Available dates and destinations are listed in the course dates section on this page.

How can I register?

Choose an available date on this page and complete the registration form, or send a programme enquiry.

Can I download the course brochure?

Yes. Use the brochure download link provided on this page.

Cell and Gene Therapy Foundations Course